| Patents for C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749) |
|---|
| 03/09/2005 | CN1192024C Method for preparing substituted triazolone |
| 03/08/2005 | US6864325 Romp with oligomeric UV-absorbers |
| 03/08/2005 | US6864219 Substituted aryl ketones |
| 03/08/2005 | US6863838 Low melting point |
| 03/03/2005 | WO2005019212A1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 03/03/2005 | WO2005019184A1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 03/03/2005 | WO2005019147A2 Pesticidally active phenol derivatives |
| 03/03/2005 | WO2005000309A3 Chemical compounds |
| 03/03/2005 | WO2005000298A3 5-membered heterocycle-based p-38 inhibitors |
| 03/02/2005 | EP1509518A1 Calcium receptor modulating agents |
| 03/02/2005 | EP1509497A1 Calcium receptor modulating arylalkylamines |
| 03/02/2005 | EP1278741B1 Muscarinic agonists |
| 03/02/2005 | EP1183091A4 Optimization of ligand affinity for rna targets using mass spectrometry |
| 03/02/2005 | CN1191063C Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders |
| 02/24/2005 | WO2005016862A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | WO2005016344A1 Piperazine derivatives for the treatment of hiv infections |
| 02/24/2005 | WO2004078730A3 Method for producing optically active amines |
| 02/24/2005 | US20050043543 Benzotriazole/HALS molecular combinations and compositions stabilized therewith |
| 02/24/2005 | US20050043307 Novel heterocycle as agonist or antagonist for nervous systems which can contain double or triple bonds with nitrogen, oxygen or sulfur with carbon or azo groups and or salts and as modulators or receptors with carriers |
| 02/24/2005 | US20050043300 Piperazine derivatives |
| 02/24/2005 | US20050042279 Pharmaceutical formulation comprising more than 15% tamoxifen |
| 02/24/2005 | CA2535665A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | CA2534866A1 Piperazine derivatives for the treatment of hiv infections |
| 02/23/2005 | EP1507769A1 Copper-catalysed ligation of azides and acetylenes |
| 02/23/2005 | EP1507541A2 Inhibitors and methods of use thereof |
| 02/23/2005 | EP1507504A1 Cycloalkyl inhibitors of potassium channel function |
| 02/23/2005 | EP0876337B1 New lh-rh antagonists with improved effectiveness |
| 02/23/2005 | CN1585756A Substituted diphenyl heterocycles useful for treating HCV infection |
| 02/23/2005 | CN1585755A Benzamide and heteroarylamide as P2X7 receptor antagonists |
| 02/23/2005 | CN1583730A Synthesis of 5-iodo-1, 4-twice substituted-1, 2, 3-trioxazole compound |
| 02/22/2005 | US6858691 Exhibit extensive delocalization of the negative charge and good activity in polymerization or in copolymerization and allow the preparation of macromolecules possessing dissociated and stable ionic functional groups |
| 02/22/2005 | US6858639 3-Arylphenyl sulfide derivative and insecticide and miticide |
| 02/22/2005 | US6858602 Compounds for the treatment of metabolic disorders |
| 02/22/2005 | CA2129039C Tri-substituted phenyl derivatives as phosphodiesterase inhibitors |
| 02/17/2005 | WO2005013982A1 Aminotriazole compounds useful as inhibitors of protein kinases |
| 02/17/2005 | WO2004092115A3 Hydroxamates as therapeutic agents |
| 02/17/2005 | WO2003104332A8 Compositions and inks containing disazo dyes |
| 02/17/2005 | US20050038035 Heterocyclic amide compounds as apolipoprotein b inhibitors |
| 02/16/2005 | EP1506962A2 Nitrogen-containing aromatic heterocycles |
| 02/16/2005 | EP1505968A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes |
| 02/10/2005 | WO2005012263A1 5-ht2b receptor antagonists |
| 02/10/2005 | WO2005012241A2 p-38 KINASE INHIBITORS |
| 02/10/2005 | WO2004060305A3 Anti-cancer medicaments |
| 02/10/2005 | US20050032848 Administering enzyme inhibitors of beta secretase, an enzyme responsible for the production of amyloid beta peptide by mediating the cleavage of amyloid precursor proteins; Alzheimer's disease; cognition activators; Down's syndrome; neurodegenerative diseases; other dementias of mixed origins |
| 02/10/2005 | DE10331675A1 Hetarylsubstituierte Pyrazolidindion-Derivate Hetarylsubstituierte pyrazolidindione derivatives |
| 02/10/2005 | CA2534990A1 P-38 kinase inhibitors |
| 02/10/2005 | CA2532505A1 5-ht2b receptor antagonists |
| 02/10/2005 | CA2531333A1 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 02/09/2005 | EP1100789B1 Substituted benzoylcyclohexandiones |
| 02/09/2005 | CN1578763A Selective herbicides based on substituted arylsulfonylaminocarbonyl triazolinones and safeners |
| 02/09/2005 | CN1188397C Process for preparation of acid chloride compounds |
| 02/03/2005 | WO2005009940A1 Novel aminobenzophenone compounds |
| 02/03/2005 | WO2004094384A3 (hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer’s disease |
| 02/03/2005 | US20050026980 Use of (3-(2-ethylphenyl)-5-methoxyphenyl)-1H-[1,2,4]-triazole for the treatment of autoimmune diseases |
| 02/03/2005 | CA2530302A1 Novel aminobenzophenone compounds |
| 02/02/2005 | EP1501810A1 Ionic liquids |
| 02/02/2005 | EP1501809A1 Triazole derivatives as tachykinin receptor antagonists |
| 02/02/2005 | EP1501808A1 Tachykinin receptor antagonists |
| 02/02/2005 | EP1501505A1 Use of (3-(2-ethylphenyl)-5-methoxyphenyl)-1h- 1,2,4 -t riazole for the treatment of autoimmune diseases |
| 02/02/2005 | CN1575284A Substituted triazole diamine derivatives as kinase inhibitors |
| 02/02/2005 | CN1575273A 3, 4-di-substituted cyclobutene-1, 2-diones as CXC-chemokine receptor antagonists |
| 02/02/2005 | CN1575177A Cxcr3 antagonists |
| 02/02/2005 | CN1572789A Use of certain crystal modifications of 1-(2, 6-difluorobenzyl)-1h-1, 2, 3-triazole-4-carboxamide in treating epilepsy |
| 02/02/2005 | CN1187343C Method for production of triazolinethione derivative |
| 02/01/2005 | US6849652 1,2,4-triazole derivative or a non-toxic salt thereof as an active ingredient for treatment of fever, pain, and inflammation |
| 02/01/2005 | US6849648 Phenylene alkyne matrix metalloproteinase inhibitors |
| 02/01/2005 | US6849636 Useful for treatment of noninsulin-dependent diabetes, hyperglycemia, obesity, insulin resistance, dyslipidemia, hyperlipidemia, hypertension, Metabolic Syndrome |
| 02/01/2005 | US6849618 Herbicidal compositions for the desiccation/ defoliation of plants |
| 02/01/2005 | US6849617 Administering Tissue factor pathway inhibitors for prophylaxis of thrombosis and cardiovascular disorders; anticoagulants |
| 01/27/2005 | WO2005007638A1 Optically active halohydrin derivative and process for producing optically active epoxy alcohol derivative from the same |
| 01/27/2005 | WO2005007631A1 Naphthylene derivatives as cytochrome p450 inhibitors |
| 01/27/2005 | WO2005006860A2 Azole derivatives and methods for making the same |
| 01/27/2005 | US20050020651 Butyric acid derivatives |
| 01/27/2005 | US20050020590 Antiinflammatory agents; autoimmune disease; bone disorders; viricides; antiproliferative agents; antiarthritic agents |
| 01/27/2005 | US20050020584 Benzamide derivatives as antagonists of orexin receptors |
| 01/27/2005 | CA2532078A1 Naphthylene derivatives as cytochrome p450 inhibitors |
| 01/26/2005 | EP1499600A1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 01/26/2005 | EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 01/26/2005 | CN1186330C Polymerizable hydrophilic ultraviolet light absorbing monomers |
| 01/25/2005 | US6846929 A hydroxyphenyl-2-benzotriazoles as light stabilizers having ultraviolet light absorbing activity; stabilizer with heat resistance, photostability, oxidation resistance |
| 01/25/2005 | CA2231201C Toilet bowl cleaning tablet |
| 01/25/2005 | CA2129455C Orally active azole derivatives |
| 01/20/2005 | WO2005005428A1 Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics |
| 01/20/2005 | WO2005005376A2 Fungicidal phenoxyphenylhydrazine derivatives |
| 01/20/2005 | WO2005005374A1 Aspartyl protease inhibitors |
| 01/20/2005 | WO2005004810A2 Arylsulfonamide derivatives |
| 01/20/2005 | US20050014938 Phenyl substituted triazoles and their use as selective inhibitors of akl5 kinase |
| 01/20/2005 | US20050014805 Hypotensive agents; antidiabetic agents; cardiovascular disorders; anticholesterol agents; anticancer agents |
| 01/20/2005 | US20050014803 Enzyme inhibitors |
| 01/20/2005 | CA2535986A1 Fungicidal phenoxyphenylhydrazine derivatives |
| 01/20/2005 | CA2529739A1 Aspartyl protease inhibitors |
| 01/19/2005 | EP1497281A2 Azole derivatives as antifungal agents |
| 01/19/2005 | EP1497270A1 Amide compounds and methods of using the same |
| 01/19/2005 | EP1496892A2 1h-benzo(f)indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 01/19/2005 | EP1496838A2 Substituted amides |
| 01/19/2005 | EP1063228B1 Cycloalkene derivatives, process for producing the same, and use |
| 01/19/2005 | CN1568310A Heterocyclic inhibitors of glycogen synthase kinase GSK-3 |
| 01/19/2005 | CN1185234C Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives |
| 01/18/2005 | US6844444 Photographic cyan coupler; synthetic intermediates |
| 01/13/2005 | WO2004099134A3 Glutaminyl based dp iv-inhibitors |